About Infraredx
Infraredx is a company based in Burlington (United States) founded in 1998 was acquired by Nipro in September 2015. Infraredx has raised $99.99 million across 13 funding rounds from investors including Nipro Corporation, GE Healthcare Equipment Finance and Sanderling Ventures. Infraredx offers products and services including Clarispro® HD-IVUS, Dualpro® IVUS+ NIRS, Makoto® Imaging System, GM-30 Inflation Device, and OKAY II® Y-Connector. Infraredx operates in a competitive market with competitors including Conavi, Acarix, Ionetix, Cleveland HeartLab and Kaminari Medical, among others.
- Headquarter Burlington, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Infraredx, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$99.99 M (USD)
in 13 rounds
-
Latest Funding Round
$20 M (USD), Debt – Conventional
Nov 05, 2013
-
Investors
Nipro Corporation
& 2 more
-
Employee Count
Not available
-
Acquired by
Nipro
(Sep 11, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Infraredx
Infraredx offers a comprehensive portfolio of products and services, including Clarispro® HD-IVUS, Dualpro® IVUS+ NIRS, Makoto® Imaging System, GM-30 Inflation Device, and OKAY II® Y-Connector.
Delivers high-resolution visualization of vessel structures for accurate diagnosis.
Identifies lipid-core plaques to predict and prevent cardiac events.
Combines technologies for comprehensive insights into vascular conditions.
Supports procedures with controlled inflation for imaging applications.
Facilitates multi-device access during intravascular procedures.
Funding Insights of Infraredx
Infraredx has successfully raised a total of $99.99M across 13 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $20 million completed in November 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Infraredx
Infraredx has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Nipro Corporation, GE Healthcare Equipment Finance and Sanderling Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biomedical investment financing and active management services.
|
Locked | Locked | Locked | |
|
Offers flexible financing and risk-sharing for healthcare industry assets globally.
|
Locked | Locked | Locked | |
|
Manufacturer of medical devices, pharmaceuticals, and regenerative medicine products
|
Locked | Locked | Locked |
Investor details for Infraredx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Infraredx
Investment portfolio details for Infraredx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Infraredx
Detailed financials for Infraredx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Infraredx Comparisons
Peer comparison for Infraredx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Infraredx
Infraredx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conavi, Acarix, Ionetix, Cleveland HeartLab and Kaminari Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Catheter-based ultrasound systems for cardiac imaging are developed.
|
|
| Locked | Locked | Locked |
A screening device for acoustic coronary artery diseases is provided.
|
|
| Locked | Locked | Locked |
Superconducting cyclotrons for PET radioisotopes are developed by Ionetix.
|
|
| Locked | Locked | Locked |
Cardiovascular biomarkers are utilized for disease prevention and management.
|
|
| Locked | Locked | Locked |
Developer of diagnostic solution for vulnerable plaque in the coronary arteries
|
Detailed competitors of Infraredx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Infraredx
Complete news archive for Infraredx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Infraredx
Infraredx was founded in 1998 and raised its 1st funding round 4 years after it was founded.
Infraredx is headquartered in Burlington, United States. It is registered at Burlington, Vermont, United States.
Infraredx is a funded company, having raised a total of $99.99M across 13 funding rounds to date.
Infraredx was founded in 1998 in Burlington, United States, within the medical devices sector. Near-infrared spectroscopic technology is utilized to design and manufacture catheter-based systems for coronary artery imaging. Plaque composition is assessed through fiber-optic NIR spectroscopy, with FDA clearance secured for detecting lipid core plaques. The product range encompasses the LipiScan NIR Coronary Imaging System, LipiScan IVUS Coronary Imaging System, and TVC Imaging System for evaluating vessel structure.
Infraredx offers Clarispro® HD-IVUS, Dualpro® IVUS+ NIRS, Makoto® Imaging System, GM-30 Inflation Device, and OKAY II® Y-Connector.
Infraredx has 3 investors. Key investors include Nipro Corporation, GE Healthcare Equipment Finance, and Sanderling Ventures.